The Superion implant acts as an indirect decompression device. Its anatomic design provides optimal fit and preserves a patient’s anatomy and ability to maintain motion. Superion acts as an extension blocker, relieving pressure on the affected nerves in the manner that one would achieve relief in a seated or flexed position. Available in multiple sizes to accommodate varying patient anatomy, Superion ensures controlled movement and minimizes post-procedure complications. Superion was developed to provide patients with a safe and effective alternative when conservative treatment has failed and laminectomy is too aggressive.

The surgery is usually done outpatient under general anesthesia or sedation (twilight anesthesia) with ½ inch to 1 inch incision for 1 level stenosis.

FDA approved, Superion is clinically shown to be effective for up to 60 months. Certain risks are associated with the use of Superion. Consult your doctor for more information regarding these risks.